A 6-year-old boy from rural Maharashtra presents with honey-crusted lesions on his face and lower extremities. Gram stain shows Gram-positive cocci in clusters. Regarding the management and epidemiology of this condition, all of the following are true EXCEPT:

Question

Accepted Answer

A. Penicillin V is the preferred oral antibiotic for impetigo caused by Streptococcus pyogenes because it has superior coverage of methicillin-resistant Staphylococcus aureus. ## Antibiotic Selection in Impetigo Management

**Key Point:** Penicillin V is **NOT** the preferred choice for empiric impetigo treatment because it has **poor coverage of MRSA and methicillin-susceptible S. aureus (MSSA)**. Penicillin V is only appropriate if *Streptococcus pyogenes* is confirmed as the sole pathogen — which is rare in modern impetigo.

### Correct Management Principles

| Scenario | First-Line Treatment | Rationale |
|----------|----------------------|-----------|
| **Localized (<2% BSA)** | Topical mupirocin | Avoids systemic exposure; high local concentration |
| **Extensive (>2% BSA) or systemic signs** | Oral cephalexin or amoxicillin-clavulanate | Covers MSSA and *S. pyogenes*; cephalosporin preferred if MRSA suspected |
| **MRSA confirmed** | Clindamycin or trimethoprim-sulfamethoxazole (TMP-SMX) | Penicillins and cephalosporins are ineffective |
| **Penicillin V** | ~~Impetigo~~ | Only for confirmed *S. pyogenes* alone (rare) |

### Why Option 3 Is Wrong

**High-Yield:** Penicillin V has **no activity against Staphylococcus aureus** (beta-lactamase production). Since *S. aureus* is now the dominant pathogen in impetigo (especially in India where MRSA prevalence is high), penicillin V is **not a suitable empiric agent**. Using penicillin V would result in treatment failure in the majority of cases.

**Clinical Pearl:** The epidemiology of impetigo has shifted dramatically over the past two decades — *S. aureus* (including MRSA) now causes >80% of impetigo cases globally. Penicillin-based monotherapy is obsolete for this indication.

**Mnemonic:** **CAMP** — Cephalosporin, Amoxicillin-clavulanate, Mupirocin (topical), Penicillin V (NOT for impetigo)

[cite:KD Tripathi 8e Ch 66]

Answer

B. Topical mupirocin is effective for localized impetigo limited to <2% body surface area and is the first-line treatment for such cases

Answer

C. Impetigo is highly contagious and spreads through direct contact; infected children should be excluded from school until lesions are covered or antibiotic therapy has been initiated for 48 hours

Answer

D. Oral cephalexin or amoxicillin-clavulanate is indicated when impetigo is extensive, involves >2% BSA, or shows signs of systemic involvement

A 6-year-old boy from rural Maharashtra presents with honey-crusted lesions on his face and lower extremities. Gram stain shows Gram-positive cocci in clusters. Regarding the management and epidemiology of this condition, all of the following are true EXCEPT:

Explanation

Antibiotic Selection in Impetigo Management

Correct Management Principles

Why Option 3 Is Wrong

Practice similar questions

Join our NEET PG community

Scenario	First-Line Treatment	Rationale
Localized (<2% BSA)	Topical mupirocin	Avoids systemic exposure; high local concentration
Extensive (>2% BSA) or systemic signs	Oral cephalexin or amoxicillin-clavulanate	Covers MSSA and S. pyogenes; cephalosporin preferred if MRSA suspected
MRSA confirmed	Clindamycin or trimethoprim-sulfamethoxazole (TMP-SMX)	Penicillins and cephalosporins are ineffective
Penicillin V	~~Impetigo~~	Only for confirmed S. pyogenes alone (rare)